EUR 0.06
(-5.84%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2022 | 4.1 Million EUR | 171.53% |
2021 | -5.74 Million EUR | -13.62% |
2020 | -5.05 Million EUR | -32.01% |
2019 | -3.82 Million EUR | -254216.87% |
2018 | 1506.00 EUR | 9.05% |
2017 | 1381.00 EUR | 75.7% |
2016 | 786.00 EUR | 78.23% |
2015 | 441.00 EUR | 6.78% |
2014 | 413.00 EUR | -97.05% |
2013 | 14 Thousand EUR | 107.18% |
2012 | -195 Thousand EUR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 Q2 | 2.9 Million EUR | 0.0% |
2022 Q4 | -1.8 Million EUR | 0.0% |
2022 Q2 | -2.55 Million EUR | 0.0% |
2022 FY | -4.35 Million EUR | 24.08% |
2021 Q4 | -2.35 Million EUR | 0.0% |
2021 Q2 | -3.38 Million EUR | 0.0% |
2021 FY | -5.74 Million EUR | -13.62% |
2020 Q2 | -1.97 Million EUR | 0.0% |
2020 FY | -5.05 Million EUR | -32.01% |
2020 Q4 | -3.07 Million EUR | 0.0% |
2019 Q4 | -1.59 Million EUR | 0.0% |
2019 FY | -3.82 Million EUR | -254216.87% |
2019 Q2 | -2.23 Million EUR | 0.0% |
2018 Q2 | 816.00 EUR | 0.0% |
2018 FY | 1506.00 EUR | 9.05% |
2018 Q4 | 690.00 EUR | 0.0% |
2017 Q4 | 577.00 EUR | 0.0% |
2017 FY | 1381.00 EUR | 75.7% |
2017 Q2 | 804.00 EUR | 0.0% |
2016 Q4 | 465.00 EUR | 0.0% |
2016 FY | 786.00 EUR | 78.23% |
2016 Q2 | 321.00 EUR | 0.0% |
2015 FY | 441.00 EUR | 6.78% |
2015 Q2 | 413.00 EUR | 0.0% |
2015 Q4 | 28.00 EUR | 0.0% |
2014 FY | 413.00 EUR | -97.05% |
2014 Q4 | 41.00 EUR | 0.0% |
2014 Q2 | 372.00 EUR | 0.0% |
2013 Q4 | 58.00 EUR | -98.34% |
2013 FY | 14 Thousand EUR | 107.18% |
2013 Q3 | 3500.00 EUR | 8054.55% |
2013 Q2 | -44.00 EUR | -101.26% |
2013 Q1 | 3500.00 EUR | 0.0% |
2012 FY | -195 Thousand EUR | 0.0% |
2012 Q1 | -48.75 Thousand EUR | 0.0% |
2012 Q2 | -48.75 Thousand EUR | 0.0% |
2012 Q3 | -48.75 Thousand EUR | 0.0% |
2012 Q4 | 3500.00 EUR | 107.18% |
2011 Q4 | -48.75 Thousand EUR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Crossject Société Anonyme | -6.13 Million EUR | 166.927% |
Spineway SA | 1.55 Million EUR | -164.732% |
Amplitude Surgical SA | 37.2 Million EUR | 88.964% |
Sartorius Stedim Biotech S.A. | 1.23 Billion EUR | 99.667% |
EssilorLuxottica Société anonyme | 16.07 Billion EUR | 99.974% |
bonyf N.V. | 26.41 Thousand EUR | -15444.787% |